Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other Non-Current Assets: 2020-2024

Historic Other Non-Current Assets for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $2.6 million.

  • Tango Therapeutics' Other Non-Current Assets fell 16.67% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 16.67%. This contributed to the annual value of $2.6 million for FY2024, which is 24.50% down from last year.
  • As of FY2024, Tango Therapeutics' Other Non-Current Assets stood at $2.6 million, which was down 24.50% from $3.4 million recorded in FY2023.
  • Tango Therapeutics' Other Non-Current Assets' 5-year high stood at $4.0 million during FY2022, with a 5-year trough of $2.3 million in FY2020.
  • Its 3-year average for Other Non-Current Assets is $3.3 million, with a median of $3.4 million in 2023.
  • Per our database at Business Quant, Tango Therapeutics' Other Non-Current Assets surged by 73.91% in 2022 and then decreased by 24.50% in 2024.
  • Tango Therapeutics' Other Non-Current Assets (Yearly) stood at $2.3 million in 2020, then remained steady at $2.3 million in 2021, then spiked by 73.91% to $4.0 million in 2022, then dropped by 15.00% to $3.4 million in 2023, then fell by 24.50% to $2.6 million in 2024.